Calcineurin inhibitor-free GVHD prophylaxis with baricitinib, abatacept, vedolizumab, and reduced-dose PTCy in pediatric acute leukemia: a prospective study: PtCy, baricitinib, abatacept, and vedolizumab to prevent GVHD.

M Perminova, L Shelikhova, M Klimentova, M Dunaykina, O Molostova, D Shasheleva, S Arakelyan, Y Skvortsova, D Balashov, I Muzalevsky, A Popov, D Pershin, A Maschan, M Maschan